402 related articles for article (PubMed ID: 26120368)
1. Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials.
Grill JD; Raman R; Ernstrom K; Aisen P; Dowsett SA; Chen YF; Liu-Seifert H; Hake AM; Miller DS; Doody RS; Henley DB; Cummings JL
Alzheimers Res Ther; 2015; 7(1):39. PubMed ID: 26120368
[TBL] [Abstract][Full Text] [Related]
2. Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program.
Cummings JL; Atri A; Ballard C; Boneva N; Frölich L; Molinuevo JL; Raket LL; Tariot PN
Alzheimers Res Ther; 2018 Nov; 10(1):116. PubMed ID: 30474567
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease progression by geographical region in a clinical trial setting.
Henley DB; Dowsett SA; Chen YF; Liu-Seifert H; Grill JD; Doody RS; Aisen P; Raman R; Miller DS; Hake AM; Cummings J
Alzheimers Res Ther; 2015; 7(1):43. PubMed ID: 26120369
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease.
Frölich L; Wunderlich G; Thamer C; Roehrle M; Garcia M; Dubois B
Alzheimers Res Ther; 2019 Feb; 11(1):18. PubMed ID: 30755255
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
[TBL] [Abstract][Full Text] [Related]
6. Current Landscape of Late-Phase Clinical Trials for Alzheimer's Disease: Comparing Regional Variation Between Subjects in Japan and North America.
Kikuchi M; Adachi N; Matsumaru N; Tsukamoto K
Pharmaceut Med; 2019 Dec; 33(6):511-518. PubMed ID: 31933241
[TBL] [Abstract][Full Text] [Related]
7. Impact of Geographic Region on the COMMANDER-HF Trial.
Ferreira JP; Cleland JGF; Lam CSP; van Veldhuisen DJ; Byra WM; La Police DA; Anker SD; Mehra MR; Leroy C; Eschwege V; Toussaint-Hacquard M; Rossignol P; Greenberg B; Zannad F
JACC Heart Fail; 2021 Mar; 9(3):201-211. PubMed ID: 33549557
[TBL] [Abstract][Full Text] [Related]
8. The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics.
Jones RW; Kivipelto M; Feldman H; Sparks L; Doody R; Waters DD; Hey-Hadavi J; Breazna A; Schindler RJ; Ramos H;
Alzheimers Dement; 2008 Mar; 4(2):145-53. PubMed ID: 18631958
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer's disease: a meta-analysis.
Li J; Wu X; Tan X; Wang S; Qu R; Wu X; Chen Z; Wang Z; Chen G
Front Aging Neurosci; 2023; 15():1257973. PubMed ID: 38020763
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit/hyperactivity disorder from 15 clinical trials across four geographic regions.
Tanaka Y; Rohde LA; Jin L; Feldman PD; Upadhyaya HP
J Child Adolesc Psychopharmacol; 2013 May; 23(4):262-70. PubMed ID: 23683141
[TBL] [Abstract][Full Text] [Related]
11. World health-related indicators.
Logan WP
World Health Stat Rep; 1976; 29(12):682-97. PubMed ID: 1014713
[TBL] [Abstract][Full Text] [Related]
12. [Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono N; Mori E; Ikejiri Y; Imamura T; Shimomura T; Hashimoto M; Yamashita H; Ikeda M
No To Shinkei; 1997 Mar; 49(3):266-71. PubMed ID: 9125732
[TBL] [Abstract][Full Text] [Related]
13. AIDS and sex tourism.
Herold ES; Van Kerkwijk C
AIDS Soc; 1992; 4(1):1, 8. PubMed ID: 12286016
[TBL] [Abstract][Full Text] [Related]
14. Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy.
Farlow MR; Grossberg GT; Meng X; Olin J; Somogyi M
Int J Geriatr Psychiatry; 2011 Dec; 26(12):1236-43. PubMed ID: 22068922
[TBL] [Abstract][Full Text] [Related]
15. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
[TBL] [Abstract][Full Text] [Related]
16. Assessing site performance in the Altair study, a multinational clinical trial.
Berthon-Jones N; Courtney-Vega K; Donaldson A; Haskelberg H; Emery S; Puls R
Trials; 2015 Apr; 16():138. PubMed ID: 25872747
[TBL] [Abstract][Full Text] [Related]
17. Progression of Alzheimer's disease during a three-year follow-up using the CERAD-NB total score: Kuopio ALSOVA study.
Hallikainen I; Hänninen T; Fraunberg M; Hongisto K; Välimäki T; Hiltunen A; Karppi P; Sivenius J; Soininen H; Koivisto AM;
Int Psychogeriatr; 2013 Aug; 25(8):1335-44. PubMed ID: 23676340
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E
J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
[TBL] [Abstract][Full Text] [Related]
19. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
Doody RS; Thomas RG; Farlow M; Iwatsubo T; Vellas B; Joffe S; Kieburtz K; Raman R; Sun X; Aisen PS; Siemers E; Liu-Seifert H; Mohs R; ;
N Engl J Med; 2014 Jan; 370(4):311-21. PubMed ID: 24450890
[TBL] [Abstract][Full Text] [Related]
20. Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry.
Ferrari R; Ford I; Greenlaw N; Tardif JC; Tendera M; Abergel H; Fox K; Hu D; Shalnova S; Steg PG;
Eur J Prev Cardiol; 2015 Aug; 22(8):1056-65. PubMed ID: 25147344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
